CGEN: SEC Form 6-K filed by Compugen Ltd.
Stocks in this Quantisnow insightHealth Care
Historical context for CGEN
Across the 21 sessions after earlier CGEN headlines, the stock closed higher 13 times and lower 8 times, with a median move of 3.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CGEN | SPY |
|---|---|---|---|
| Sep 8, 2026 | Compugen to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference | -1.2% | -0.5% |
| Aug 3, 2026 | Compugen Reports Second Quarter 2026 Results | +1.3% | +1.4% |
| Jul 21, 2026 | Compugen to Participate in BTIG Biotechnology Conference 2026 | +6.4% | +0.8% |
| Jul 20, 2026 | Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026 | -1.3% | -0.2% |
| Jun 18, 2026 | Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress | +1.0% | +0.8% |
| Jun 11, 2026 | Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 | +4.1% | +1.7% |
Quantisnow market dataNASDAQ
CGEN
Compugen Ltd.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2000
Get push alerts for CGEN
Full CGEN profile on Quantisnow Follow CGEN and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time